Analyst Rating: Will Cyteir Therapeutics Inc (CYT) Stock Do Better Than the Market?

Friday, June 30, 2023 09:35 AM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Cyteir Therapeutics Inc (CYT) Stock Do Better Than the Market?

InvestorsObserver is giving Cyteir Therapeutics Inc (CYT) an Analyst Rating Rank of 16, meaning CYT is ranked higher by analysts than 16% of stocks. The average price target for CYT is $2.666 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating CYT a Buy today. Find out what this means to you and get the rest of the rankings on CYT!

See Full CYT Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Cyteir Therapeutics Inc Stock Today?

Cyteir Therapeutics Inc (CYT) stock is trading at $2.61 as of 9:35 AM on Friday, Jun 30, an increase of $0.69, or 35.68% from the previous closing price of $1.92. Volume today is above average. So far 1,729,980 shares have traded compared to average volume of 42,433 shares. The stock has traded between $2.49 and $2.69 so far today. Click Here to get the full Stock Report for Cyteir Therapeutics Inc stock.